VALVULAR SURGERY PREVALENCE AND MORTALITY PATTERNS: ANALYSIS FROM A REFERENCE CARDIOVASCULAR CENTER

Main Article Content

Preeti Batheja
Dr. Anurag Rawat
Tariq Rafique
Amber Shafique
Ahmad AL-Qunbar
Dr. Kainat Abid

Keywords

Cardiac surgeries, Cardiovascular surgery, National Cardiovascular Institute of Pakistan, Operational mortality, Descriptive research, Valvular surgery, Myocardial revascularization, Postoperative complications, Surgical site infection, Mortality rate

Abstract

Background: This study aims to characterize cardiac surgeries, delineate their procedures, and assess operational mortality at the National Cardiovascular Institute of Pakistan.


Methods: Descriptive research encompassed all patients over 18 who underwent cardiovascular surgery at the National Cardiovascular Institute "Carlos Alberto Peschiera Carrillo" in Pakistan in 2022. A total of 503 cardiac procedures were analyzed.


Results: Of the patients, 63.6% (320) underwent surgical procedures, with isolated valvular surgery being the most common (27.0%), followed by myocardial revascularization surgery (21.9%). The overall mortality rate was 4.5%, with elective surgeries exhibiting a 2.8% mortality rate and emergency surgeries showing a 14.3% mortality rate. The prevalent postoperative complications included paroxysmal atrial fibrillation (14.0%) and surgical site infection (10.3%).


Conclusion: Valvular surgery, either alone or in combination with other procedures, was the most frequently performed surgery. The achieved mortality rate was deemed satisfactory for a reference center.

Abstract 58 | PDF Downloads 27

References

1. Ades, P. A., Keteyian, S. J., Wright, J. S., Hamm, L. F., Lui, K., Newlin, K., Shepard, D. S., & Thomas, R. J. (2017). Increasing cardiac rehabilitation participation from 20% to 70%: a Million Hearts Cardiac Rehabilitation Collaborative road map. Mayo Clinic proceedings,
2. Benedetto, U., Dimagli, A., Kaura, A., Sinha, S., Mariscalco, G., Krasopoulos, G., Moorjani, N., Field, M., Uday, T., & Kendal, S. (2022). Determinants of outcomes following surgery for type A acute aortic dissection: the UK National Adult Cardiac Surgical Audit. European Heart Journal, 43(1), 44-52.
3. Diab, M., Lehmann, T., Bothe, W., Akhyari, P., Platzer, S., Wendt, D., Deppe, A.-C., Strauch, J., Hagel, S., & Günther, A. (2022). Cytokine hemoadsorption during cardiac surgery versus standard surgical care for infective endocarditis (REMOVE): results from a multicenter randomized controlled trial. Circulation, 145(13), 959-968.
4. Fairbairn, T., Kemp, I., Young, A., Ronayne, C., Barton, J., Crowe, J., McQuade, L., Clarkson, N., Sionas, M., & Tobin, A. (2022). Effect of transcatheter aortic valve implantation vs surgical aortic valve replacement on all-cause mortality in patients with aortic stenosis: a randomized clinical trial. Jama, 327(19), 1875-1887.
5. Fearon, W. F., Zimmermann, F. M., De Bruyne, B., Piroth, Z., van Straten, A. H., Szekely, L., Davidavičius, G., Kalinauskas, G., Mansour, S., & Kharbanda, R. (2022). Fractional flow reserve–guided PCI as compared with coronary bypass surgery. New England Journal of Medicine, 386(2), 128-137.
6. Gammie, J. S., Chu, M. W., Falk, V., Overbey, J. R., Moskowitz, A. J., Gillinov, M., Mack, M. J., Voisine, P., Krane, M., & Yerokun, B. (2022). Concomitant tricuspid repair in patients with degenerative mitral regurgitation. New England Journal of Medicine, 386(4), 327-339.
7. Gaudino, M., Di Franco, A., Alexander, J. H., Bakaeen, F., Egorova, N., Kurlansky, P., Boening, A., Chikwe, J., Demetres, M., & Devereaux, P. J. (2022). Sex differences in outcomes after coronary artery bypass grafting: a pooled analysis of individual patient data. European Heart Journal, 43(1), 18-28.
8. Lawton, J. S., Tamis-Holland, J. E., Bangalore, S., Bates, E. R., Beckie, T. M., Bischoff, J. M., Bittl, J. A., Cohen, M. G., DiMaio, J. M., & Don, C. W. (2022). 2021 ACC/AHA/SCAI guideline for coronary artery revascularisation: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 145(3), e4-e17.
9. Lloyd-Jones, D. M., Allen, N. B., Anderson, C. A., Black, T., Brewer, L. C., Foraker, R. E., Grandner, M. A., Lavretsky, H., Perak, A. M., & Sharma, G. (2022). Life’s Essential 8: Updating and Enhancing the American Heart Association’s Construct of Cardiovascular Health: A presidential advisory from the American Heart Association. Circulation, 146(5), e18-e43.
10. Members, W. C., Lawton, J. S., Tamis-Holland, J. E., Bangalore, S., Bates, E. R., Beckie, T. M., Bischoff, J. M., Bittl, J. A., Cohen, M. G., & DiMaio, J. M. (2022). 2021 ACC/AHA/SCAI guideline for coronary artery revascularisation: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Journal of the American College of Cardiology, 79(2), e21-e129.
11. Nashef, S. A., Roques, F., Hammill, B. G., Peterson, E. D., Michel, P., Grover, F. L., Wyse, R. K., & Ferguson, T. B. (2002). Validation of European system for cardiac operative risk evaluation (EuroSCORE) in North American cardiac surgery. European Journal of Cardio-Thoracic Surgery, 22(1), 101–105.
12. Navar, A. M., Fine, L. J., Ambrosius, W. T., Brown, A., Douglas, P. S., Johnson, K., Khera, A. V., Lloyd-Jones, D., Michos, E. D., & Mujahid, M. (2022). Earlier treatment in adults with a high lifetime risk of cardiovascular diseases: What prevention trials are feasible and could change clinical practice? Report of a National Heart, Lung, and Blood Institute (NHLBI) Workshop. American Journal of Preventive Cardiology, p. 12, 100430.
13. Nguyen, T. C., Thourani, V. H., Nissen, A. P., Habib, R. H., Dearani, J. A., Ropski, A., Crestanello, J. A., Shahian, D. M., Jacobs, J. P., & Badhwar, V. (2022). The effect of COVID-19 on adult cardiac surgery in the United States in 717 103 patients. The Annals of Thoracic Surgery, 113(3), 738–746.
14. Timmis, A., Vardas, P., Townsend, N., Torbica, A., Katus, H., De Smedt, D., Gale, C. P., Maggioni, A. P., Petersen, S. E., & Huculeci, R. (2022). European Society of Cardiology: Cardiovascular Disease Statistics 2021. European Heart Journal, 43(8), 716–799.
15. Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Alonso, A., Beaton, A. Z., Bittencourt, M. S., Boehme, A. K., Buxton, A. E., Carson, A. P., & Commodore-Mensah, Y. (2022). Heart disease and stroke statistics—2022 update: a report from the American Heart Association. Circulation, 145(8), e153-e639.
16. Vaduganathan, M., Mensah, G. A., Turco, J. V., Fuster, V., & Roth, G. A. (2022). The global burden of cardiovascular diseases and risk: a compass for future health. In (Vol. 80, pp. 2361-2371): American College of Cardiology Foundation Washington DC.
17. Wang, P., Yuan, D., Zhang, C., Zhu, P., Jia, S., Song, Y., Tang, X., Xu, J., Li, T., & Zeng, G. (2022). High fibrinogen-to-albumin ratio with type 2 diabetes mellitus is associated with poor prognosis in patients undergoing percutaneous coronary intervention: 5-year findings from a large cohort. Cardiovascular diabetology, 21(1), 46.
18. Wenger, N. K., Lloyd-Jones, D. M., Elkind, M. S., Fonarow, G. C., Warner, J. J., Alger, H. M., Cheng, S., Kinzy, C., Hall, J. L., & Roger, V. L. (2022). Call to action for cardiovascular disease in women: epidemiology, awareness, access, and delivery of equitable health care: a presidential advisory from the American Heart Association. Circulation, 145(23), e1059-e1071.

Most read articles by the same author(s)

1 2 3 > >>